期刊
NATURE IMMUNOLOGY
卷 17, 期 12, 页码 1459-1466出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/ni.3577
关键词
-
类别
资金
- Crohn's and Colitis Foundation of America
- Alliance for Lupus Research
- US National Institutes of Health [R01HL 108006, R01105550DK, P01HL018646, F31CA183529, R00CA168997, R01AI070807, P01AI073489]
- German Research Foundation (Deutsche Forschungsgemeinschaft)
CD4(+) effector T cells (T-eff cells) and regulatory T cells (T-reg cells) undergo metabolic reprogramming to support proliferation and immunological function. Although signaling via the lipid kinase PI(3)K (phosphatidylinositol-3-OH kinase), the serine-threonine kinase Akt and the metabolic checkpoint kinase complex mTORC1 induces both expression of the glucose transporter Glut1 and aerobic glycolysis for T-eff cell proliferation and inflammatory function, the mechanisms that regulate T-reg cell metabolism and function remain unclear. We found that Toll-like receptor (TLR) signals that promote T-reg cell proliferation increased PI(3)K-Akt-mTORC1 signaling, glycolysis and expression of Glut1. However, TLR-induced mTORC1 signaling also impaired T-reg cell suppressive capacity. Conversely, the transcription factor Foxp3 opposed PI(3)K-Akt-mTORC1 signaling to diminish glycolysis and anabolic metabolism while increasing oxidative and catabolic metabolism. Notably, Glut1 expression was sufficient to increase the number of T-reg cells, but it reduced their suppressive capacity and Foxp3 expression. Thus, inflammatory signals and Foxp3 balance mTORC1 signaling and glucose metabolism to control the proliferation and suppressive function of Treg cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据